These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1666894

  • 1. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
    Nixon JS, Bottomley KM, Broadhurst MJ, Brown PA, Johnson WH, Lawton G, Marley J, Sedgwick AD, Wilkinson SE.
    Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [Abstract] [Full Text] [Related]

  • 3. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS, Wang-Weigand S, Bohne R, Kozaci LD, Hollander AP.
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [Abstract] [Full Text] [Related]

  • 4. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T, Poole AR.
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [Abstract] [Full Text] [Related]

  • 5. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP.
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [Abstract] [Full Text] [Related]

  • 6. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM, Becher G, Bendele AM, Biesinger R, Bluhm H, Boer J, Deng H, Dodd R, Essers M, Feuerstein T, Gallagher BM, Gege C, Hochgürtel M, Hofmann M, Jaworski A, Jin L, Kiely A, Korniski B, Kroth H, Nix D, Nolte B, Piecha D, Powers TS, Richter F, Schneider M, Steeneck C, Sucholeiki I, Taveras A, Timmermann A, Van Veldhuizen J, Weik J, Wu X, Xia B.
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [Abstract] [Full Text] [Related]

  • 7. Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo.
    Lewis EJ, Bishop J, Bottomley KM, Bradshaw D, Brewster M, Broadhurst MJ, Brown PA, Budd JM, Elliott L, Greenham AK, Johnson WH, Nixon JS, Rose F, Sutton B, Wilson K.
    Br J Pharmacol; 1997 Jun; 121(3):540-6. PubMed ID: 9179398
    [Abstract] [Full Text] [Related]

  • 8. Role of metalloproteinases in human osteoarthritis.
    Woessner JF, Gunja-Smith Z.
    J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
    Milner JM, Rowan AD, Elliott SF, Cawston TE.
    Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
    [Abstract] [Full Text] [Related]

  • 10. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [Abstract] [Full Text] [Related]

  • 11. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
    Kozaci LD, Brown CJ, Adcocks C, Galloway A, Hollander AP, Buttle DJ.
    Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
    Cai L, Suboc P, Hogue DA, Fei DT, Filvaroff EH.
    J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
    Girard MT, Matsubara M, Fini ME.
    Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V, Goldberg R, Peppard J, Rediske J, Melton R, Hu SI, Wang W, Duvander C, Heinegård D.
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [Abstract] [Full Text] [Related]

  • 15. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP.
    J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
    [Abstract] [Full Text] [Related]

  • 16. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
    Todhunter RJ, Yeh LA, Sheldon A, Grisanzio L, Walker SL, Burton-Wurster N, Lust G.
    Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
    [Abstract] [Full Text] [Related]

  • 17. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM, Elliott SF, Cawston TE.
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [Abstract] [Full Text] [Related]

  • 18. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M, Lesur C, Thomas M, Chomel A, Anract P, de Nanteuil G, Pastoureau P.
    Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
    [Abstract] [Full Text] [Related]

  • 19. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, Cole AA.
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [Abstract] [Full Text] [Related]

  • 20. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
    Homandberg GA, Hui F.
    Arch Biochem Biophys; 1996 Oct 15; 334(2):325-31. PubMed ID: 8900407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.